Trial intelligence / Profile preview

Dual Trigger vs GnRH-a Trigger for Elective Fertility Preservation

NCT04992468Phase 4Completed

Sponsor
Fundació Santiago Dexeus Font
Start
Oct 2021
Primary completion
Apr 2023
Modality
rProtein (Recombinant Protein), Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of recombinant human chorionic gonadotrophin in infertility, sponsored by Fundació Santiago Dexeus Font. Started Oct 2021; status: completed.

02

Drugs

recombinant human chorionic gonadotrophin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT04992468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04992468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call